IMCR Overview
Upcoming Projects (IMCR)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (IMCR)
-
A look at the interim results from the P2 trial evaluating darovasertib(IDE196) and crizotinib synthetic lethal combination in metastatic uveal melanoma patients
Tickers: IDYA, PFE, IMCR
Executed On: Nov 01, 2022 at 03:00 PM EDT -
Discussing KIMMTRAK®(tebentafusp-tebn) for the treatment of unresectable or metastatic uveal melanoma in light of its recent FDA approval- 2nd look
Ticker: IMCR
Executed On: Mar 25, 2022 at 04:00 PM EDT -
Discussing KIMMTRAK®(tebentafusp-tebn) for the treatment of unresectable or metastatic uveal melanoma in light of its recent FDA approval.
Ticker: IMCR
Executed On: Mar 18, 2022 at 12:30 PM EDT
Upcoming & Overdue Catalysts (IMCR)
-
Don’t see a catalyst related to the company you care about? Create your own!
Strategic Initiatives (IMCR)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
